Rovina Pharma And Intermediate Chemicals Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 18-07-2024
- Paid Up Capital ₹ 0.10 M
as on 18-07-2024
- Company Age 4 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2023)
- Profit -39.32%
(FY 2023)
- Ebitda -32.01%
(FY 2023)
- Net Worth 14.37%
(FY 2023)
- Total Assets 14.37%
(FY 2023)
About Rovina Pharma And Intermediate Chemicals
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Shrikant Narkhede, Kota Rao, and Anil Manavi serve as directors at the Company.
- CIN/LLPIN
U51909MH2019PTC335003
- Company No.
335003
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Dec 2019
- Date of AGM
23 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Dombivli East, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Rovina Pharma And Intermediate Chemicals Private Limited offer?
Rovina Pharma And Intermediate Chemicals Private Limited offers a wide range of products and services, including Mosquito & Insect Repellent, Mosquito Repellent, Industrial Chemicals & Supplies, Chemical Intermediates.
Who are the key members and board of directors at Rovina Pharma And Intermediate Chemicals?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shrikant Narkhede  | Director | 25-Dec-2019 | Current |
| Anil Manavi | Director | 25-Dec-2019 | Current |
| Kota Rao | Director | 25-Dec-2019 | Current |
Financial Performance of Rovina Pharma And Intermediate Chemicals.
Rovina Pharma And Intermediate Chemicals Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 39.32% decrease in profit. The company's net worth Soared by an impressive increase of 14.37%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rovina Pharma And Intermediate Chemicals?
In 2023, Rovina Pharma And Intermediate Chemicals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Eurocel Chemical Industries Private LimitedActive 2 years 11 monthsShrikant Narkhede is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Rovina Pharma And Intermediate Chemicals?
Unlock and access historical data on people associated with Rovina Pharma And Intermediate Chemicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rovina Pharma And Intermediate Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rovina Pharma And Intermediate Chemicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
